Blog Coverage CRA International Announces Acquisition of C1 Consulting; Set to Strengthen its Pharma Consulting Business

Upcoming AWS Coverage on Navigant Consulting Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 1, 2017 / Active Wall St. blog coverage looks at the headline from Charles River Associates (CRA) International Inc. (NASDAQ: CRAI) as the Company announced on January 31, 2017, an agreement where it has acquired substantially all the assets of C1 Consulting. C1 Consulting is a life sciences strategy consulting firm which enables pharmaceutical and biotech Companies maximize their revenues and achieve business growth through several commercialization strategies based on advanced analytics, customer insights and therapy area expertise. Financial terms of the acquisition were not disclosed as of now and the acquisition is expected to be accretive to earnings for FY17. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of CRA International’s competitors within the Management Services space, Navigant Consulting, Inc. (NYSE: NCI), announced on January 19, 2017, that it will report its financial results for Q4 and full year ended December 31, 2016, on Thursday, February 16, 2017, before the market opens. AWS will be initiating a research report on Navigant Consulting in the coming days.

Today, AWS is promoting its blog coverage on CRAI; touching on NCI. Get all of our free blog coverage and more by clicking on the links below:

http://www.activewallst.com/registration-3/?symbol=CRAI

http://www.activewallst.com/registration-3/?symbol=NCI

Breaking down the agreement

Under terms of the transaction, CRA International purchased substantially all the assets of C1 Consulting in an attempt to retain the services of all employees (about 70 employees) of the acquired Company. The five key individuals viewing their positions as CRA International Vice Presidents are: Elizabeth Rountree, Rob Sederman, Ned Kitfield, Kevin Brubacher, and Robert Broadnax. C1 Consulting was founded over a decade ago in 2004 and offered a unique insight through market research and data analytics in the specialty disease segment.

The newly acquired team will join Charles River Associates Life Sciences Practice and offer additional dimensions to Charles River client offerings across the segment. The acquisition of C1 Consulting offers the Company with new offices across San Francisco, California; Lucerne, Switzerland; and Summit, New Jersey while bringing a boost in its staff numbers across the Boston and New York city locations.

C1’s Growth Strategy

C1 Consulting views massive growth through the execution of this agreement. CRA International, being a well-established and leading consulting firm, shares C1 Consulting’s commitment to deliver high value information and strategies to clients to make well-informed decisions. Subject to the execution of this union, C1 Consulting is set to receive additional resources, elevated access to respected academics, and enhanced collaborative offerings.

CRA’s unified business

CRA International views this agreement as a complementary business. According to Greg Bell, VP and Life Sciences Practice Leader, this acquisition will help address most of the complex business problems. The industry experience from CRA International and analytical experience from C1 Consulting brings complimentary client management and offers greater depth to the services offered and helps clients while addressing a majority of issue across the globe.

Stock Performance

On Tuesday, January 31, 2017, the stock closed the trading session at $33.23, marginally down 0.48% from its previous closing price of $33.39. A total volume of 29.26 thousand shares have exchanged hands. CRA International’s stock price rallied 12.05% in the last three months, 21.83% in the past six months, and 81.91% in the previous twelve months. The Company’s shares are trading at a PE ratio of 29.17 and have a dividend yield of 1.69%. At Tuesday’s closing price, the stock’s net capitalization stands at $274.81 million.

Earnings Alerts: The Company will webcast its Q4 2016 financial results conference call on February 16, 2017 at 9:00 a.m. ET. The conference call will be hosted by President and Chief Executive Officer, Paul Maleh, and Chief Financial Officer, Chad Holmes. Prior to the call, the Company will post the press release announcing its Q4 2016 financial results and supplemental financial information, including prepared CFO remarks, on the “Investor Relations” section of its website.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 454044